Tuesday, August 11, 2020

PSMA-targeted radiopharmaceutical clinical trials in the US

Now that the VISION trial of Lu-177-PSMA-617 is no longer recruiting, some patients are wondering if they can still get PSMA-targeted radiopharmaceuticals in the US, without traveling to Germany, Australia, India, etc. Here is a list of trials that are active, still open to recruitment, or will soon be recruiting. 

Unless otherwise noted, they are all for men who are: 

  • metastatic
  • castration-resistant 
  • have had at least one taxane chemotherapy
  • at least one of the advanced androgen receptor therapies (e.g., Zytiga, Xtandi, Erleada, or Nubeqa)
  • no Xofigo
  • PSMA-avid on a PSMA PET/CT scan

Links that have contact information are provided.

1 comment:

  1. I spoke with MSK in NY today 8/28/20. They are offering an observational study, not specifically a clinical trial. NCT #04030338. Using Ga68 as a diagnostic tool; not for treatment purposes. Not likely covered by insurance. Cost approx $7,500. Need at least two consecutive PSA tests reflecting minimum 0.2 within last 6 mos.